126 results on '"Kirgizov, K."'
Search Results
2. The experience of relapsed Burkitt lymphoma treatment with targeted drugs and autologous/allogeneic stem cell transplantation
3. The efficacy of the TRK inhibitor entrectinib in patients with extracranial NTRK fusion-positive tumors
4. Modern approaches to the treatment of relapses and refractory forms of Langerhans cell histiocytosis. Literature review
5. Consensus on the diagnosis and treatment of PROS (PIK3CA-related overgrowth spectrum). Russian version
6. Results of hematopoietic stem cell transplantation in children with acute leukemia: a single-center experience
7. Modern methods of therapy in the development of life-threatening complications in a patient after repeated allogeneic hematopoietic stem cell transplantation: review of the literature and clinical case
8. A clinical case of immune-mediated pneumonitis after nivolumab in a patient with Burkitt lymphoma
9. Early T-cell precursor leukemia: questions of diagnosis, treatment and description of own clinical case
10. Clinical case: allogeneic transplantation of hematopoietic stem cells for Fanconi anemia in the onset of refractory anemia with excess blasts
11. Radiation dermatitis: current view on pathogenesis, principles of profilaxis and treatment
12. Hematopoietic stimulants in the treatment and prevention of graft-versus-host disease
13. Haematopoietic stem cell transplantation for severe autoimmune diseases in children : a review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation
14. Minimal residual disease in B-precursor acute lymphoblastic leukemia: Clinical significance on post-induction treatment
15. Pediatric acute lymphoblastic leukemia: multicenter study of the treatment by the protocol ALL IC-BFM 2002
16. Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)
17. The use of multistage immunotherapy to achieve remission before haploidentical hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia and the treatment of complications of this therapy in the early post-transplant period: a review of the literature and a clinical case
18. Clinical features of methods for collecting hematopoietic stem cells in patients with malignant neoplasms weighing up to 15 kg and early age
19. Successful diagnosis and treatment of fusariosis in patient with acute leukemia
20. Blinatumomab in acute lymphoblastic leukemia treatment: features of therapy organization, supplement issues and therapy-related toxicity. Literature review and own experience
21. Treatment of acute lymphoblastic leukemia in children by ALL IC-BFM 2002 protocol: results of multicenter retrospective study
22. The use of Jelonet dressings in the treatment of drug toxicity in autologous stem cell transplantation in children. Clinical case presentation
23. Treatment of Ewingʼs sarcoma in children and adolescents: new vision
24. DETECTION OF MINIMAL TUMOR CELLS FOR THE DIAGNOSIS AND TREATMENT MONITORING OF CHILDREN WITH NEUROBLASTOMA
25. Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
26. Case of successful therapy with rituximab at patient with transplant associated Thrombotic microangiopathy hemolytic uremic syndrome after repeated allogenic hematopoietic stem cell transplantation: AB47
27. A problem of multi-drug resistant infectious in pediatric lymphoma treatment
28. Treatment of severe infectious complications caused by multidrug-resistant Klebsiella pneumoniae in children with malignant neoplasms of the hematopoietic system: experience of the Research Institute of Pediatric Oncology and Hematology at N.N. Blokhin Russian Cancer Research Center
29. The latest trends in improving CAR-T cell therapy: from leukemia to solid malignant tumors
30. Predictive biomarkers of inhibitors immune checkpoints therapy in malignant tumors
31. BCG vaccine–related complications in patients with primary immunodeficiencies after allogeneic hematopoietic stem cell transplantation
32. Successful use of hydroxymethylquinoxaline dioxide in complex antimicrobial therapy in patients with fulminant infectious complications in induced hematopoesis aplasia by gram-negative agents
33. RITUXIMAB AS AN EFFECTIVE AGENT IN CONDITIONING REGIMEN TO PREVENT GVHD IN PAEDIATRIC PATIENTS: PH-AB227
34. A CASE OF NEPHRONECROSIS AFTER ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: PH-AB109
35. LOW DOSE CYCLOPHOSPHAMIDE AND FLUDARABINE-BASED CONDITIONING REGIMEN FOR PEDIATRIC MATCHED RELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE APLASTIC ANEMIA: PH-P580
36. A modern view of assessment and correction of the nutritional status in infants with tumor neoplasms
37. Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases : updated guidelines and recommendations from the EBMT autoimmune diseases working party (ADWP) and the joint accreditation committee of EBMT and ISCT (JACIE)
38. Veno-occlusive liver disease after hematopoietic stem cell transplantation and high-dose chemotherapy regimens. Literature review
39. Diagnosis and treatment of post-transfusion iron overload in pediatric hematology: literature review
40. Differential diagnosis of pneumonia in pediatric patients with oncohematological disease in condition of new coronavirus infection COVID-19
41. Thrombotic microangiopathy associated with hematopoietic stem cell transplantation: general characteristics and an example from clinical practice
42. Possibilities of treating skin lesions in the graft versus host disease using the Pulsavac Plus wound repair system
43. Optimization of methods for collecting peripheral hematopoietic stem cells in children with cancer: literature review
44. Results of allogeneic hematopoietic stem cell transplantation in patients with chronic granulomatous disease at the Russian Children’s Clinical Hospital
45. Chronic “graft versus host” disease after allogeneic hematopoietic stem cell transplantation: basic characteristics, pathogenetic mechanisms, treatment strategies and problems of clinical practice
46. Skin damage after the hematopoietic stem cell transplantation. Literature review
47. The efficacy of the regimens of “graft versus host” disease prophylaxis after hematopoietic stem cell transplantation from unrelated donors in children: single center experience
48. Skin involvement in Burkitt lymphoma: rare clinical case
49. New approaches in the treatment of solid tumors in children and adolescents using the targeted drug entrectinib
50. SIMULATION TRAINING OF ONCOLOGICAL NURSES IN THE SKILLS OF CARING FOR IMPLANTABLE VENOUS PORT SYSTEMS. EXPERIENCE OF NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY NAMED AFTER N. N. BLOKHIN
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.